Africa: Gilead Underneath Fireplace for Not Promoting HIV Drug Lenacapavir to MSF
Pharmaceutical firm Gilead Sciences has come below mounting stress after refusing to promote its breakthrough HIV prevention drug, lenacapavir, on to Médecins Sans Frontières (MSF), regardless of repeated requests. In an open letter, the group renewed its repeated requests to California-based Gilead to promote the drug, saying the corporate is obstructing lenacapavir’s rollout. MSF stated it had sought to…